Mean (SD) change in serum ravulizumab concentration over time. The graph presents values before ravulizumab (lower values) and after ravulizumab (higher values) dosing at every visit for each patient subgroup. Dashed horizontal line indicates 175 μg/mL, the threshold for complete C5 inhibition. EOS, end of study.